Explore evidence

100 %Fever was present in 100% of patients with cryptococcal meningitis.

Côte d'Ivoireméningite cryptococciqueobserved 2008 to 2011published 2017Journal de mycologie medicaleeurope_pmcdocument of 11 observations

54 %Among hospitalized HIV-positive adults in West Africa, AIDS-defining conditions were the underlying cause of hospitalization in 54% of patients.

Côte d'IvoireVIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

22 monthsThe mean time on highly active antiretroviral therapy (HAART) was 22 months among HIV-infected adults in Abidjan.

Côte d'IvoireVIH/sidapublished 2007Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 2 observationsDOI 10.1097/qai.0b013e31805d8ad0

43 yearsThe average age of the 36 HIV-infected patients was 43±12 years.

Côte d'IvoireVIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

1 patientLipodystrophy was present in one patient.

Côte d'Ivoirelipodystrophypublished 2009Antiviral therapyeurope_pmcdocument of 11 observations

2.3 per_100_person-yearsThe incidence of death among HIV-infected adults receiving antiretroviral treatment was 2.3 per 100 person-years.

Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

65 %CRF02 (>65%) cocirculates with other HIV-1 variants in Senegal and Côte d'Ivoire.

Côte d'Ivoire · SénégalVIH/sidapublished 2009AIDS Research and Human RetrovirusesOpenAlexdocument of 3 observations

2 per_person_yearMortality among people living with HIV/AIDS during the first year of antiretroviral therapy implementation was 2–3% per person-year.

Côte d'IvoireVIH/sidapublished 2009Medecine tropicale : revue du Corps de sante colonialeurope_pmcdocument of 5 observations

19 %At month 24 after ART initiation, 19% of patients in active follow-up had virus resistant to at least one antiretroviral drug.

Côte d'IvoireVIH/sidapublished 2013Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 11 observations

45.1 %In Côte d'Ivoire, the frequency of multiple infections with msp1 was 45.1%.

Côte d'Ivoirepaludismepublished 2016Journal of parasitology researcheurope_pmcdocument of 8 observationsDOI 10.1155/2016/3074803

24.4 %Hospital mortality among hospitalized HIV-infected patients was 24.4%.

Côte d'IvoireVIH/sidapublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations

7.27 log10_copies_per_mLAt ART initiation, median HBV-DNA was 7.27 log10 copies/mL among 73 HIV-HBV co-infected patients from Côte d'Ivoire.

Côte d'Ivoirehépatite Bpublished 2019Liver international : official journal of the International Association for the Study of teurope_pmcdocument of 4 observationsDOI 10.1111/liv.13975

376 USD_per_DALY_averterdThe incremental cost-effectiveness ratio when comparing the resistance test policy with the no switch policy was $376 per DALY averted.

Côte d'IvoireVIH/sidapublished 2025The lancet. HIVeurope_pmcdocument of 6 observations

48 patientsDuring 34 months of follow-up, 48 patients (77.4%) received first-line treatment.

Côte d'IvoireVIH/sidaobserved 34 monthspublished 2010Le Mali medicaleurope_pmcdocument of 17 observations

9 %Among hospitalized HIV-positive adults in West Africa who died, cryptococcosis was a fatal disease in 9% of deaths.

Côte d'Ivoirecryptococcosis · VIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

40 %Malaria case prevalence was reduced by 40% in the larvicide group.

Côte d'Ivoirepaludismeobserved post-intervention periodHAL · Unilimdocument of 54 observations

64 %The study included 36 HIV-infected patients, including 23 women (64%), with a sex-ratio M/F of 0.57.

Côte d'IvoireVIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

65.8 %Among 550 participants, 362 (65.8%) achieved virologic success at week 48.

Côte d'Ivoiretuberculose · VIH/sidapublished 2023AIDS (London, England)europe_pmcdocument of 6 observations

13 %The prevalence of sickle cell trait was 13% in the population analyzed.

Côte d'Ivoiretrait drépanocytaireHAL · Unilimdocument of 23 observations

8 %Neuromeningeal cryptococcosis accounted for 8% of AIDS-defining reasons for hospitalization.

Côte d'Ivoireneuromeningeal cryptococcosis · VIH/sidapublished 2013Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 16 observations

85.4 %Among adolescent girls living with HIV in Côte d'Ivoire, 85.4% reported lack of information about the HPV vaccine as a barrier to vaccination.

Côte d'Ivoireinfection à HPV · VIH/sidaobserved 2024–2025HAL · Unilimdocument of 69 observations

84 %After 6 months of antiretroviral therapy, 84% of patients in Abidjan, Côte d'Ivoire reached viral-load undetectability.

Côte d'IvoireVIH/sidapublished 2008Bulletin of the World Health Organizationeurope_pmcdocument of 3 observations

2.9 %Of the 312 patients initially classified as HIV-2, 9 (2.9%) were reclassified as HIV-1&2.

Côte d'IvoireVIH/sidaobserved 2012published 2014Journal of the International AIDS Societyeurope_pmcdocument of 8 observations

10 %Among hospitalized HIV-positive adults in West Africa, cerebral toxoplasmosis was diagnosed in 10% of patients.

Côte d'Ivoirecerebral toxoplasmosis · VIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

22.25 %Malaria case prevalence in the LLIN group was 22.25% (572/2571) pre-intervention.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations